TAP311

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAP311, covering 2013-12-02 to 2013-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients [Phase 1]